Analysis of HLA-DRB1-related alleles in Japanese patients with lung cancer - Relationship to genetic susceptibility and resistance to lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 9, 1998, Pages 511-516

  Tokumoto, Hiroshi ^a  

^a Komatsu Hospital   (Japan)

Author keywords

DRB1*0901; DRB1*1302; Hematological malignancy; Lung cancer; Polymerase chain reaction restriction fragment length polymorphism analysis

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; JAPAN; LEUKEMIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0031667690     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050207     Document Type: Article

References (32)

1. Apple RJ Erlich HA Klitz W, Manos MM, Becker TM, Wheeler CM (1994) HLA-DR-DQ associations with cervical carcinoma show papilloma virus-type specificity. Nat Genet 6:157-162
2. Coleman N, Stanley MA (1994) Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix. Cancer 14:884-892
3. Davenport MP, Quinn CL, Chicz RM, Green BN, Willis AC, Lane WS, Bell JI, Hill AVS (1995) Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain. Proc Natl Acad USA 92:6567-6571
4. Dellon AZ, Rogentine GN, Chreitien PB (1975) Prolonged survival in bronchogenic carcinoma associated with HLA antigens Aw 19 and HLA-A5. J Natl Cancer Inst 54:1283-1286
5. Ford CHJ, Newman CE, Mackintosh P (1981) HLA frequency and prognosis in lung cancer. Br J Cancer 43:610-614
6. Fujisao S, Matsushita S, Nishi T, Nishimura Y (1996) Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSES random peptide library. Hum Immunol 45:131-136
7. Futaki G, Kobayashi H, Sato K, Taneichi M, Katagiri M (1995) Naturally processed HLA-DR9/DR53 (DRB1*0901/ DRB4*0101)-bound peptides. Immunogenetics 42:299-301
8. Gibofsky A, Winchester R, Hansen J, Patarroyo M, Dupont B, Paget S, Lahita R, Halper J, Fotino M, Yunis E, Kunkel HG (1978) Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 21:S134-S138
9. Henderson BE, Ross RK, Pike MC (1991) Toward the primary prevention of cancer. Science 254:1131-1137
10. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennet S, Brewster D, McMichael AJ, Greenwood BM (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature 352:595-600
11. Howell WM, Leung ST, Jones DB, Nakshabendi I, Hall MA, Lanchbury JS, Ciclitira PJ, Wright DH (1995) HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum Immunol 43:29-37
12. Kawai T, Tani K, Okubo T, Suzuki H, Okamura A, Minami M, Katoh K (1994) HLA antigens in Japanese patients with high titer anti-ribonucleoprotein antibodies. Ann Rheum Dis 53:426-427
13. Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB (1994) Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet 54:497-505
14. Kumai M, Adachi T, Unno T (1990) Association between HLA antigen and birch pollen allergy in Japanese subjects. Am J Rhinol 4:19-23
15. Markman M, Braine H, Abeloff MD (1984) Histocompatibility antigens in small cell carcinoma in lung cancer. Cancer 54:2943-2945
16. Matsuki K, Juji T, Tokunaga K, Takamizawa M, Maeda H, Soda M, Nomura Y, Segawa M (1990) HLA antigens in Japanese patients with myasthenia gravis. J Clin Invest 86:392-399
17. Nomura Y, Ehara M, Matsuki K, Juji T, Segawa M (1993) HLA haplotype in myathenia gravis (MG) of Japanese children: correlative studies between MG patients and their normal siblings and patients. Ann NY Acad Sci 681:581-583
18. Ota M, Seki T, Fukushima H, Tsuji K, Inoko H (1992) HLA DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39:187-202
19. Page A, Nakhle G, Mercier C, Verdant A, Page P, Dontigny L, Allard S, Gauthier JJ, Cossette R (1987) Surgical treatment of bronchiogenic carcinoma. The importance of staining in evaluating late survival. Can J Surg 30:96-99
20. Prazak J, Mericka O, Chytry J (1990) Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinoma. J Cancer Res Clin Oncol 116:525-527
21. Rogentine GN, Dellon AL, Chretein PB (1977) Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. Cancer 39:2345-2347
22. Romano PJ, Bartholomew M, Smith PJ, Kloszewski F, Stryker J, Houck J, Vesell ES (1991) HLA antigens influence resistance to lung carcinoma. Hum Immunol 31:236-240
23. Sastre-Garau X, Loste M-N, Vincent-Salomon A, Favre M, Mourel E, Dela Rochefordiere A, Durand J-C, Tartour E, Lepage V, Charron D (1996) Decreased frequency of HLA-DRB1*13 alleles in frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 69:159-164
24. Senger DPS, McLeish WA, Stewart THM, Harris JE (1977) HLA antigens in bronchogenic carcinoma. Oncology 34:143-145
25. Shimura T, Hagihara M, Takebe K, Munkhbat B, Okada T, Kato H, Nagamachi Y, Tsuji K (1994) The atudy of tumor necrosis factor beta gene polymorphism in lung cancer patients. Cancer 73:1184-1188
26. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW (1973) HLA in solid tumors. Cancer Res 33:648-650
27. Terasaki PI, McClelland JD (1964) Microdroplet assay of human serum cytotoxins, Nature 204:998-1002
28. Terasaki P, Perdue ST, Mikey MR (1977) HLA frequencies in cancer: a second study. In: Mulvihill JJ, Miller RW, Fraumeni JF (eds) Genetics of human cancer. Raven, New York, pp 321-328
29. Thomson G (1981) A review of theoretical aspects of HLA and disease association. Theor Popul Biol 20:168-208
30. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS (1995) Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 232:1065-1069
31. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523-526
32. Zhou G-P, Guo Y-Q, Ji Y-H, Zhang G-L (1994) Major histocompatibility complex class II antigens in steroid-sensitive nephrotic syndrome in chinese children. Pediatr Nephrol 8:140-141